Contact

Representative before the EPO

Technology company logo thumb
no operation time available
2 offices
Technology Company

Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

Representative before the EPO

Company dna wp thompson
no operation time available
1034.16
4 offices
active in Legal Services

Anne Rachel Burton Williams has worked on the following 7 EPO patent applications which have been published in the last five years:

EP12722820

PHARMACEUTICAL COMPOSITION OF ROSUVASTATIN CALCIUM

IPC classification:
A61K 9/16, A61K 9/20, A61K 9/50, A61K 31/505
Applicant:
AstraZeneca UK Limited
Agent:
Anne Rachel Burton Williams, AstraZeneca PLC
Status:
GRANT OF PATENT INTENDED
EP12727922

PROCESS FOR PREPARING HETEROCYCLIC COMPOUNDS INCLUDING TRANS-7-OXO-6-(SULPHOOXY)-1,6-DIAZABICYCLO[3,2,1]OCTANE-2-CARBOXAMIDE AND SALTS THEREOF

IPC classification:
C07D 211/60, C07D 471/08
Applicant:
AstraZeneca AB
Agent:
Anne Rachel Burton Williams, AstraZeneca PLC
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12738589

AZETIDINE DERIVATIVES FOR TREATMENT OF MELANIN RELATED DISORDERS

IPC classification:
A61K 31/397, A61K 31/407, A61P 3/04, C07D 491/044, C07D 491/048
Applicant:
AstraZeneca AB
Agent:
Anne Rachel Burton Williams, AstraZeneca PLC
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP14173061

Cyclopropyl amide derivatives

IPC classification:
A61K 31/495, A61P 25/00, C07D 207/12, C07D 211/40, C07D 231/12, C07D 233/36, C07D 239/26, C07D 243/08, C07D 295/18
Applicant:
AstraZeneca AB
Agent:
Anne Rachel Burton Williams, AstraZeneca PLC
Agent:
Multiple attorneys, Ropes & Gray International LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12841851

METHODS AND COMPOSITIONS FOR TREATING OR PREVENTING ATTENTION DEFICIT HYPERACTIVITY DISORDER

IPC classification:
A01N 37/00
Agent:
Sarah Elizabeth Roques, J A Kemp
Agent:
Anne Rachel Burton Williams, AstraZeneca PLC
Status:
EXAMINATION IN PROGRESS
EP13787637

COMPOSITIONS OF STATINS AND OMEGA-3 FATTY ACIDS

IPC classification:
A61K 9/42
Agent:
Anne Rachel Burton Williams, AstraZeneca PLC
Agent:
Anne Rachel Burton Williams, WP Thompson
Status:
EXAMINATION REQUESTED
EP14772420

THERAPEUTIC POLYMERIC NANOPARTICLES AND METHODS OF MAKING AND USING SAME

IPC classification:
A61K 9/51, A61K 31/00, A61K 47/12
Agent:
Anne Rachel Burton Williams, AstraZeneca AB
Agent:
Anne Rachel Burton Williams, AstraZeneca PLC
Status:
GRANT OF PATENT INTENDED

Please Sign in to use this feature